| Literature DB >> 35684222 |
Theysshana Visuvanathan1,2, Leslie Thian Lung Than1, Johnson Stanslas3, Shu Yih Chew1, Shalini Vellasamy2.
Abstract
Fenugreek (Trigonella foenum-graecum L.) is a medicinal plant that has been used as a food condiment as well as for its multiple therapeutic characteristics since ancient times. Fenugreek plant grows up to 60 cm in height, and its seeds are golden-yellow rhomboidal-shaped. Though fenugreek is more commonly known for its seeds, the leaves and stem have also been reported to have medicinal uses. These properties exhibited are due to the content of the secondary metabolites, also known as phytochemicals, in the fenugreek plant. Such metabolites are alkaloids, saponins, tannins, phenols, and many others. Fenugreek has been used traditionally for numerous indications, such as aid in labour, lactation stimulant, and laxatives. In modern research, there have been several animal and clinical studies that have shown therapeutic effects of fenugreek when taken orally. Fenugreek is a suitable plant candidate with a high prospect of being used as a credible medicinal plant to derive new drugs. This review aims to summarize the physical and chemical properties of fenugreek and its bioactive compounds that have been isolated for medicinal purposes and discusses the traditional and pharmacological uses of fenugreek.Entities:
Keywords: alkaloids; fenugreek; pharmacological potential; phytochemicals; saponins; trigonella foenum-graecum
Year: 2022 PMID: 35684222 PMCID: PMC9182856 DOI: 10.3390/plants11111450
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Vitamin profiles and their respective concentrations in fenugreek [5].
| Particular | Plant part | Units | Value/100 g |
|---|---|---|---|
| Ascorbic acid | Seed | mg | 12–23 |
| Ascorbic acid | Leaves | mg | 52.0 |
| Pyridoxine | Seed | mg | 0.60 |
| Retinol | Seed | IU | 60–100 |
| Niacin | Seed | mg | 6.0 |
| β-carotene | Seed | µg | 96 |
| β-carotene | Leaves | mg | 2.3 |
| Thiamine | Seed | µg | 340 |
| Thiamine | Leaves | µg | 40 |
| Riboflavin | Seed | µg | 290 |
| Riboflavin | Leaves | µg | 310 |
| Folic acid | Seed | µg | 84 |
Chemical constituents of fenugreek seed [8].
| Chemical Constituents of Fenugreek Seed | |
|---|---|
| Alkaloids | trimethylamine, neurin, trigonelline, choline, gentianine, carpaine betain |
| Amino acids | isoleucine, 4-hydroxyisoleucine, histidine, leucine, lysine, L-tryptophan, argenine |
| Saponins | graecunins, fenugrin B, fenugreekine, trigofoenosides A-G |
| Steroidal sapinogens | yamogenin, diosgenin, smilagenin, sarsasapogenin, tigogenin, neotigogenin, gitogenin, yuccagenin, saponaretin |
| Flavonoids | quercetin, rutin, vitexin, isovitexin |
| Fibres | gum, neutral detergent fibre |
| Lipids | triacylglycerols, diacylglycerols, monoacylglycerols, phosphatidylcholine, phosphatidylethanoamine, free fatty acids |
| Others | coumarin, lipids, vitamins, minerals. 28% mucilage; 22% proteins; 5% of a stronger-swelling, bitter fixed oil |
Figure 1Chemical constituent of fenugreek and its chemical structure and pharmacological effect. (A) 4-hydroxyisoleucine, known to have antidiabetic properties. (B) Trigonelline, known for its hypoglycaemic activity. (C) Galactomannan, a compound with hypoglycaemic effect. (D) Diosgenin, associated with dyslipidemia. (E) Vitexin, an antioxidant compound. (F) Isovitexin, an isomer of vitexin with similar properties.
Traditional medicinal uses of fenugreek.
| Traditional Uses | Reference |
|---|---|
| Demulcent, lactation stimulant, and laxatives | [ |
| Aid labour, period cramps, and tonic for metabolism | [ |
| Increase milk production in breastfeeding mothers and relieve menstrual cramps, treat cellulitis, boils, and tuberculosis | [ |
| Dysmenorrhoeal and postmenopausal symptoms | [ |
| Topical effect in soothing irritation caused by eczema | [ |
| Lower the amount of calcium oxalate, which is a crystal that causes the formation of kidney stones | [ |
| Detoxifying agent in removing toxic wastes, dead cells, and trapped protein through the lymphatic system | [ |
Pharmaceutical properties of fenugreek.
| Pharmaceutical Properties | Plant Part | Effects | Model | Reference |
|---|---|---|---|---|
| Hypoglycaemic | Seed | Fenugreek improves peripheral glucose utilization and tolerance | Non-insulin-dependent diabetic patients | [ |
| Improvement in glycaemic control among patients with mild type 2 diabetes mellitus | Patients with type II diabetes | [ | ||
| Dialyzed fenugreek seed extract was comparable to that of insulin | Alloxan-induced diabetic mice | [ | ||
| Improves glucose control as well as decreasing insulin resistance | Double-blind placebo study | [ | ||
| Fenugreek seed polyphenols improved insulin signalling and sensitivity compared to metformin-treated rats | Fructose-fed rats | [ | ||
| Reduction in serum glucose and an increase in liver glycogen | Type 2 diabetic rat | [ | ||
| Concurrent administration of fenugreek increased the bioavailability of metformin | Rat animal model | [ | ||
| Hypocholesterolemic | Seed | Reduction in total cholesterol and low-density lipoprotein (LDL) | Hypercholesterolemia patients | [ |
| Lower blood lipids, total cholesterol, and triglycerides without affecting the high-density lipoprotein | Patients with coronary heart disease | [ | ||
| 18 to 20% reduction in plasma and liver cholesterol | Ethanolic fenugreek seed-extract-fed rats | [ | ||
| Lower LDL, total cholesterol, and triglycerides | Fenugreek-seed-powder-treated newly diagnosed type II diabetes patients | [ | ||
| Immunomodulatory | Seed | Stimulatory effect on the body and organ weight, haemagglutinin titre, quantitative haemolysis assay, late-type hypersensitivity response, plaque-forming assay, phagocytic activity, and capacity of macrophages | Swiss albino mice treated with aqueous fenugreek extract | [ |
| Stimulation of the humoral immunity and has anti-inflammatory properties | Mice treated with ethanolic fenugreek extract | [ | ||
| Regulates the expression of pro-inflammatory marker and immunoregulator marker M1 and M2, respectively | THP-1 macrophages | [ | ||
| Elevation of the CD4+ and CD8+ values | Streptozotocin-induced diabetic rats | [ | ||
| Antimicrobial | Seed, Leaves and Stem | Methanolic extract had antibacterial affect, but the aqueous extract did not show any activity. The magnitude of effects differs with the plant parts and species of microorganism, as well as the extraction solvent used | Well diffusion involving | [ |
| Anticancer | Seed | Potent cytotoxic effect of whole extract compared to purified compound | Prostate cancer cell lines, breast cancer cell lines, and pancreatic cancer cell lines | [ |
| Selective cytotoxicity effect of fenugreek extract | T cell lymphoma | [ | ||
| Alcoholic fenugreek extract showed in vitro cytotoxicity | IMR-32, a neuroblastoma cell line, and HT29, a cancer cell line | [ | ||
| Decrease in cell viability and early apoptotic changes | MCF-7 cells, a breast cancer cell line | [ | ||
| Anti-metastatic effect, induced the inhibition of cell migration and increase in late apoptosis, upregulation of p53 | MCF-7 and SK-BR3 breast cancer cell lines | [ | ||
| IC50 at 25 μg/mL, better pancreatic tissue, higher survival rate | BXPC-3 pancreatic cancer cell line and albino mice | [ | ||
| Antioxidative | Seed | Radical scavenging activity | Biochemical assay | [ |
| Protective effects on lipid peroxidation and enzymatic antioxidant | Cyclophosphamide-treated mice | [ | ||
| Highest superoxide and free radical scavenging due to high phenolic compound | NBT assay and H2O2 scavenging | [ | ||
| Positive effect in the regulation of hepatic enzymes | 12-month-old mice | [ | ||
| Increase in antioxidant radical scavenging activity | DPPH and ABTS assays | [ | ||
| Hormonal effects | Seed | Larger pain reduction and duration of pain decreased | Double-blind, randomized, placebo-controlled trial | [ |
| Reduction in lower abdominal pain | Patients with primary dysmenorrhea | [ | ||
| Improvement in bone structure and strength | Ovariectomised Wistar rats | [ | ||
| Increase in milk production | Pregnant Sprague–Dawley rats | [ | ||
| Modulation of the insulin/GH/IGF-1 axis, stimulation by insulin, and oxytocin secretion | Pregnant Sprague–Dawley rats | [ | ||
| Fat metabolism | Seed | Helps to speed up weight reduction by improving digestion and metabolism | Fat-induced obese rat | [ |
| Suppresses hunger by increasing the sense of fullness, which aids weight loss | Fat-induced obese rat | [ | ||
| Accelerating cholesterol metabolism and reversing cholesterol transport, as well as blocking 3-hydroxy-3-methylglutaryl coenzyme A reductase in serum and liver | In vivo | [ | ||
| Neuroprotective effects | Seed | Fenugreek-saponins-inhibited apoptosis and acetylcholinesterase (AChE) activity | Rats | [ |
| Substantial neuroprotective impact | Aluminium-chloride-induced neurotoxicity mouse | [ | ||
| Avoiding rotational behaviour and restoring SNC (substantia nigra compact) neuron and MDA (malondialdehyde) levels | Trigonella-fed mouse | [ |